Health In Tech Inc (HIT)

Health In Tech Inc witnessed eight transactions d'initiés recently, totaling approximately 99,178 USD in sales. Directors and officers executed these divestments following a negative earnings report. The stock price declined 15.6% over ninety days, reflecting broader market pressure as insiders reduced their equity positions ahead of upcoming fiscal disclosures.
Ticker: HIT Exchange: NAS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Health In Tech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Hayes Timothy Non-Executive Director
Transaction date
Sale
Price
292.09
Quantity 900 +27.0%
Value US$132,348
Hayes Timothy DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
314.65
Quantity 63,873
Value US$1,388,396
Hasan Zain Syed Chief Growth Officer Officer
Transaction date
Planned sale
Price
406.30
Quantity 66,912 +32.9%
Value US$2,730,700
Hayes Timothy Non-Executive Director
Transaction date
Sale
Price
0.91
Quantity 12,000 -9.0%
Value US$10,920
Hasan Zain Syed Chief Growth Officer Officer
Transaction date
Proposed sale
Price
0.94
Quantity 18,334
Value US$17,170
Hasan Zain Syed Chief Growth Officer Officer
Transaction date
Proposed sale
Price
0.94
Quantity 18,334
Value US$17,170
Hayes Timothy DIRECTOR Non-Executive Director
Transaction date
Proposed sale
Price
0.92
Quantity 1,000
Value US$100,000
Hayes Timothy Non-Executive Director
Transaction date
Sale
Price
0.93
Quantity 5,730 -4.1%
Value US$5,329
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-15 2026-09-14 S Sale Non-Executive Director
900 +27.0%
292.09
US$132,348
900 +27.0% 292.09 US$132,348
2026-09-14 2026-09-14 PrS Proposed sale

DIRECTOR

Non-Executive Director
63,873
314.65
US$1,388,396
63,873 314.65 US$1,388,396
2026-09-14 2026-09-11 PlS Planned sale

Chief Growth Officer

Officer
66,912 +32.9%
406.30
US$2,730,700
66,912 +32.9% 406.30 US$2,730,700
2026-09-11 2026-09-11 S Sale Non-Executive Director
12,000 -9.0%
0.91
US$10,920
12,000 -9.0% 0.91 US$10,920
2026-09-10 2026-09-11 PrS Proposed sale

Chief Growth Officer

Officer
18,334
0.94
US$17,170
18,334 0.94 US$17,170
2026-09-10 2026-09-11 PrS Proposed sale

Chief Growth Officer

Officer
18,334
0.94
US$17,170
18,334 0.94 US$17,170
2026-09-14 2026-09-10 PrS Proposed sale

DIRECTOR

Non-Executive Director
1,000
0.92
US$100,000
1,000 0.92 US$100,000
2026-09-11 2026-09-09 S Sale Non-Executive Director
5,730 -4.1%
0.93
US$5,329
5,730 -4.1% 0.93 US$5,329